Sponsor Dossier
Strides Pharma Science
Sponsor Dossier for Strides Pharma Science. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ALDIQ
- Brand: ALINIVIR
- Brand: AMELIA-35
- Brand: AMITRIPTYLINE-STR
- Brand: AMOXAPIN
- Brand: ANASTROZOLE
- Brand: APL-FINASTERIDE
- Brand: ARW
About
Strides Pharma Science is an Australian Private Company with ABN 44635036734, registered in NSW and currently active.
Portfolio
Strides Pharma Science has 118 brands on the ARTG, of which 34 are indexable and 33 have Product Information on file. The company has 2 brands with at least one PBS-listed item, and no brands with PBAC outcomes or AusPARs on record.
Therapeutic focus
The company's therapeutic portfolio is distributed across the following areas: — Neurology: 30 brands — Infectious Disease: 22 brands — Cardiology: 18 brands — Oncology: 11 brands — Endocrinology: 8 brands — Ophthalmology: 6 brands — Immunology: 5 brands — Gastroenterology: 4 brands — Haematology: 4 brands — Reproductive Health: 3 brands — Pain & Anaesthesia: 2 brands — Other: 1 brand — Musculoskeletal: 1 brand — Psychiatry: 1 brand — Respiratory: 1 brand — Dermatology: 1 brand
PBS footprint
Strides Pharma Science has 2 brands with at least one PBS-listed item, with the latest PBS schedule date their portfolio touched being 2026-05-01.